It has been shown that HAS2 mRNA can be regulated posttranscriptionally in fibroblasts following glucocorticoid treatment (49) and in osteosarcoma cells by the natural antisense RNA HAS2-AS1 (50). Here, HAS2 is linked to osteosarcoma.